Serina Therapeutics, Inc.SERNYSE

Revenue (LTM)

$56000

-98.2% YoY

Net Income (LTM)

$-11M

-311.4% YoY

Free Cash Flow

$-17M

Revenue CAGR (5Y)

-49.6%

Marginsimproving

FCF($0.0B)

Now unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	3↑5528.1%	1↓83.5%	3↑530.6%	0↓98.2%
Gross Profit	-1	3↑347.7%	1↓83.5%	3↑512.6%	-0↓104.5%
Operating Income	-10	-2↑84.3%	-2↓39.2%	-3↓37.8%	-17↓444.8%
Net Income	-11	-1↑88.4%	-3↓112.1%	5↑296.4%	-11↓311.4%
EBITDA	-9	-1↑85.9%	-3↓112.1%	6↑327.1%	-10↓277.2%
EPS Diluted	-10.14	-8.05↑20.6%	-2.49↑69.1%	0.63↑125.3%	-1.51↓339.7%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	1	1↑10.8%	1↑10.4%	8↑1081.2%	4↓51.8%
Total Current Assets	2	2↓2.1%	2↑9.8%	8↑210.6%	6↓25.5%
Total Assets	4	3↓19.6%	3↑2.8%	9↑176.7%	7↓25.0%
Total Current Liabilities	5	9↑67.4%	10↑12.4%	1↓86.0%	2↑67.4%
Total Liabilities	9	15↑61.2%	21↑36.8%	41↑100.7%	6↓84.9%
Total Equity	-5	-12↓131.3%	-17↓45.5%	-32↓87.6%	1↑102.0%
Total Debt	6	13↑109.7%	18↑37.3%	3↓81.0%	0↓92.2%
Net Debt	6	13↑118.7%	17↑38.5%	-4↓123.9%	-3↑18.4%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-8	-2↑71.2%	-2↑7.8%	-2↓19.3%	-17↓592.1%
Capital Expenditure	-0	-0↓442.2%	-0↑91.1%	-1↓5105.5%	-0↑95.6%
Free Cash Flow	-8	-2↑69.9%	-2↑11.6%	-3↓42.9%	-17↓475.8%
Stock-Based Comp	0	0	0↓91.4%	0↑251.6%	3↑10280.0%
Net Change in Cash	-2	-0↑80.8%	0↑162.1%	7↑3160.1%	-4↓155.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance